Anna Polli
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Advanced Breast Cancer Therapies
- Lung Cancer Diagnosis and Treatment
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 38
- Advanced Breast Cancer Therapies 9
-
- Breast Cancer Treatment Studies 10
- Co-authors
- Benjamin Solomon (21 shared papers)Alice Tsang Shaw (18 shared papers)Gabriella Piscitelli (6 shared papers)Tony S.K. Mok (16 shared papers)Carlo I. Ferrari (2 shared papers)Ikram Shah Ismail (2 shared papers)Maurice F. Scanlon (2 shared papers)Todd Michael Bauer (16 shared papers)
- Journals
- Annals of Oncology (13 papers)European Journal of Cancer (9 papers)Journal of Clinical Oncology (7 papers)Journal of Thoracic Oncology (6 papers)Future Oncology (5 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Anna Polli
59 papers receiving 6.9k citations
Anna Polli's Hit Papers
Peers
Comparison fields: 5 of 105
- Pulmonary and Respiratory Medicine 4.4k
- Cancer Research 1.2k
- Endocrinology, Diabetes and Metabolism 575
- Oncology 678
- Genetics 628
Countries citing papers authored by Anna Polli
This map shows the geographic impact of Anna Polli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Polli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Polli more than expected).
Fields of papers citing papers by Anna Polli
This network shows the impact of papers produced by Anna Polli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Polli. The network helps show where Anna Polli may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Polli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer Hit paper breakdown → | 2013 | 2903 |
| 2 | First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer Hit paper breakdown → | 2020 | 817 |
| 3 | A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea Hit paper breakdown → | 1994 | 541 |
| 4 | Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases Hit paper breakdown → | 2015 | 528 |
| 5 | 2000 | 439 | |
| 6 | 2000 | 270 | |
| 7 | 2005 | 245 | |
| 8 | Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study Hit paper breakdown → | 2024 | 190 |
| 9 | Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study Hit paper breakdown → | 2022 | 166 |
| 10 | 1999 | 97 | |
| 11 | 2022 | 95 | |
| 12 | 2017 | 90 | |
| 13 | 2006 | 89 | |
| 14 | 2012 | 62 | |
| 15 | 1992 | 53 | |
| 16 | 2000 | 53 | |
| 17 | 2017 | 52 | |
| 18 | 2012 | 49 | |
| 19 | 2016 | 44 | |
| 20 | 2023 | 40 |
About Anna Polli
Anna Polli is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Genetics, Oncology and Molecular Biology, having authored 63 papers that have together received 7.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (38 papers), Estrogen and related hormone effects (11 papers), Breast Cancer Treatment Studies (10 papers), Advanced Breast Cancer Therapies (9 papers), Melanoma and MAPK Pathways (8 papers), Bone health and treatments (4 papers), Pituitary Gland Disorders and Treatments (3 papers) and Bone health and osteoporosis research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.4k citations), Cancer Research (1.2k citations), Endocrinology, Diabetes and Metabolism (575 citations), Oncology (678 citations) and Genetics (628 citations). Anna Polli has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Benjamin Solomon, Alice Tsang Shaw, Gabriella Piscitelli, Tony S.K. Mok, Carlo I. Ferrari, Ikram Shah Ismail, Maurice F. Scanlon, Todd Michael Bauer, Dong‐Wan Kim and Geoffrey Liu. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.